1527 related articles for article (PubMed ID: 19197972)
21. Osteosarcoma in New Zealand 1981-7: an overview.
Mills HJ; Horne G; Devane P
N Z Med J; 1995 Nov; 108(1011):458-9. PubMed ID: 8538963
[TBL] [Abstract][Full Text] [Related]
22. Adverse impact of regional lymph node involvement in osteosarcoma.
Thampi S; Matthay KK; Goldsby R; DuBois SG
Eur J Cancer; 2013 Nov; 49(16):3471-6. PubMed ID: 23867123
[TBL] [Abstract][Full Text] [Related]
23. Rural patients are at risk for increased stage at presentation and diminished overall survival in osteosarcoma.
Wendt R; Gao Y; Miller BJ
Cancer Epidemiol; 2019 Aug; 61():119-123. PubMed ID: 31212223
[TBL] [Abstract][Full Text] [Related]
24. Primary osteosarcoma of bone. Clinicopathologic investigation of 243 cases, with necropsy studies in 54.
Uribe-Botero G; Russell WO; Sutow WW; Martin RG
Am J Clin Pathol; 1977 May; 67(5):427-35. PubMed ID: 266360
[TBL] [Abstract][Full Text] [Related]
25. Comparative aspects of osteosarcoma. Dog versus man.
Withrow SJ; Powers BE; Straw RC; Wilkins RM
Clin Orthop Relat Res; 1991 Sep; (270):159-68. PubMed ID: 1884536
[TBL] [Abstract][Full Text] [Related]
26. Characteristics and prognostic factors of osteosarcoma of the jaws: a retrospective cohort study.
Lee RJ; Arshi A; Schwartz HC; Christensen RE
JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):470-7. PubMed ID: 25811167
[TBL] [Abstract][Full Text] [Related]
27. Making a case for the socioeconomic determinacy of survival in osteosarcoma.
Nathan SS; Healey JH
Clin Orthop Relat Res; 2013 Mar; 471(3):784-91. PubMed ID: 22972655
[TBL] [Abstract][Full Text] [Related]
28. Twenty-year outcome of prevalence, incidence, mortality and survival rate in patients with malignant bone tumors.
Xu Y; Shi F; Zhang Y; Yin M; Han X; Feng J; Wang G
Int J Cancer; 2024 Jan; 154(2):226-240. PubMed ID: 37596989
[TBL] [Abstract][Full Text] [Related]
29. Patterns of bone sarcomas as a second malignancy in relation to radiotherapy in adulthood and histologic type.
Wu LC; Kleinerman RA; Curtis RE; Savage SA; Berrington de González A
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1993-9. PubMed ID: 22964827
[TBL] [Abstract][Full Text] [Related]
30. Demographic determinants of survival in osteosarcoma.
Nathan SS; Healey JH
Ann Acad Med Singap; 2012 Sep; 41(9):390-9. PubMed ID: 23052433
[TBL] [Abstract][Full Text] [Related]
31. Incidence Trends in the Diagnosis of Giant Cell Tumor of Bone in Sweden Since 1958.
Rockberg J; Bach BA; Amelio J; Hernandez RK; Sobocki P; Engellau J; Bauer HC; Liede A
J Bone Joint Surg Am; 2015 Nov; 97(21):1756-66. PubMed ID: 26537163
[TBL] [Abstract][Full Text] [Related]
32. Osteosarcoma: improvement in survival limited to high-grade patients only.
Jawad MU; Cheung MC; Clarke J; Koniaris LG; Scully SP
J Cancer Res Clin Oncol; 2011 Apr; 137(4):597-607. PubMed ID: 20514491
[TBL] [Abstract][Full Text] [Related]
33. Prognosis of Primary Osteosarcoma in Elderly Patients: A Comparison between Young and Elderly Patients.
Tsuchie H; Emori M; Nagasawa H; Miyakoshi N; Murahashi Y; Shimizu J; Mizushima E; Yamashita T; Shimada Y
Med Princ Pract; 2019; 28(5):425-431. PubMed ID: 30991396
[TBL] [Abstract][Full Text] [Related]
34. Perinatal factors associated with clinical presentation of osteosarcoma in children and adolescents.
Endicott AA; Morimoto LM; Kline CN; Wiemels JL; Metayer C; Walsh KM
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27860191
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors for survival in patients with high-grade osteosarcoma using the Surveillance, Epidemiology, and End Results (SEER) Program database.
Duchman KR; Gao Y; Miller BJ
Cancer Epidemiol; 2015 Aug; 39(4):593-9. PubMed ID: 26002013
[TBL] [Abstract][Full Text] [Related]
36. Bone sarcoma incidence in the Netherlands.
Goedhart LM; Ho VKY; Dijkstra PDS; Schreuder HWB; Schaap GR; Ploegmakers JJW; van der Geest ICM; van de Sande MAJ; Bramer JA; Suurmeijer AJH; Jutte PC
Cancer Epidemiol; 2019 Jun; 60():31-38. PubMed ID: 30903831
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology of bone tumors in Mexico City: retrospective clinicopathologic study of 566 patients at a referral institution.
Baena-Ocampo Ldel C; Ramirez-Perez E; Linares-Gonzalez LM; Delgado-Chavez R
Ann Diagn Pathol; 2009 Feb; 13(1):16-21. PubMed ID: 19118777
[TBL] [Abstract][Full Text] [Related]
38. Which Factors Affect Survival in Patients With Upper Limb Osteosarcoma?
Restrepo DJ; Huayllani MT; Boczar D; Sisti A; Spaulding AC; Carter RE; Moran SL; Parker AS; Perdikis G; Forte AJ
Anticancer Res; 2019 Sep; 39(9):5027-5031. PubMed ID: 31519610
[TBL] [Abstract][Full Text] [Related]
39. AgeStandardized Incidence Rates and Survival of Osteosarcoma in Northern Thailand.
Pruksakorn D; Phanphaisarn A; Pongnikorn D; Daoprasert K; Teeyakasem P; Chaiyawat P; Katruang N; Settakorn J
Asian Pac J Cancer Prev; 2016; 17(7):3455-8. PubMed ID: 27509991
[TBL] [Abstract][Full Text] [Related]
40. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
